Vantage Consulting Group Inc Amgen Inc Transaction History

Vantage Consulting Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $22,071 - $26,822	-84 Reduced 9.67%	785 $245,000
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $268 - $324	-1 Reduced 0.11%	869 $247,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $7,159 - $8,076	-28 Reduced 3.12%	870 $250,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $32,578 - $40,447	-149 Reduced 14.23%	898 $241,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $1,285 - $1,520	-6 Reduced 0.57%	1,047 $232,000
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $42,674 - $52,012	189 Added 21.88%	1,053 $254,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $38,935 - $49,471	-170 Reduced 16.44%	864 $226,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $7,182 - $8,100	32 Added 3.19%	1,034 $233,000
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $461 - $513	-2 Reduced 0.2%	1,002 $244,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $50,432 - $55,791	-230 Reduced 18.64%	1,004 $243,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $18,893 - $21,622	95 Added 8.34%	1,234 $278,000
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $43,090 - $50,486	203 Added 21.69%	1,139 $242,000
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $218,630 - $242,555	936 New	936 $228,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $70,789 - $82,493	-319 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $69,025 - $82,196	319 New	319 $73,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vantage Consulting Group Inc with notifications on news.